跳至主要内容
临床试验/CTRI/2019/03/018336
CTRI/2019/03/018336已完成未知

A Two Arm, Randomized, controlled, double blinded Study on Ayurvedic management of Type-2 Diabetes

Jivanti Welfare and Charitable Trust0 个研究点目标入组 226 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
226

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Known / diagnosed Type-2 diabetics picked up from screened population with >60 score on IDRS
  • 2. without hypertension and obesity
  • 3. Those on oral hypo glycemic drugs [any OHA]
  • 4. Subjects with HbA1C ââ?°Â¥ 6.4%

排除标准

  • 1. Morbid Obesity [BMI ââ?°Â¥ 40 kg/m2]
  • 2. Subjects with conditions such as uncontrolled hypertension (persistent BP > 180/ 100 mm of Hg after two consecutive recordings and also by checking from their earlier medical records) or severe range of obesity [BMI ââ?°Â¥ 40 kg/m2]
  • 3. History of a major/ minor surgery in the past 3 months.
  • 4. History of tuberculosis within past 3 years.
  • 5. History of head injury, neurological or psychiatric disorder in the past
  • 6. Pregnancy and lactation

研究者

发起方
Jivanti Welfare and Charitable Trust

相似试验

进行中(未招募)
1 期
A Randomized, Double Blind, Two Arms, Controlled Phase I/II Safety and Efficacy Study on MesoCellA-Ortho Tissue Engineered Product Intraarticularly Administrated in Adult Patients with Osteoarthrosis
EUCTR2019-005000-17-PLJagiellonian University200
进行中(未招募)
1 期
A study to compare if 30mg of oral Dydrogesterone is as good, tolerable and safe as 600mg of intravaginal capsules for luteal support in IVF pregnancies. This study will be conducted at several study sites and neither the patient or the doctor will know which of the two different treatments a patient will receive.Female infertilityMedDRA version: 14.1Level: LLTClassification code 10003540Term: Assisted fertilizationSystem Organ Class: 100000004865
EUCTR2012-002215-26-ESAbbott Laboratories GmbH1,066
进行中(未招募)
1 期
A study to compare if 30mg of oral Dydrogesterone is as good, tolerable and safe as 600mg of intravaginal capsules for luteal support in IVF pregnancies. This study will be conducted at several study sites and neither the patient or the doctor will know which of the two different treatments a patient will receive.Female infertilityMedDRA version: 15.1Level: LLTClassification code 10003540Term: Assisted fertilizationSystem Organ Class: 100000004865
EUCTR2012-002215-26-BEAbbott Laboratories GmbH1,066
进行中(未招募)
1 期
A study to compare if 30mg of oral Dydrogesterone is as good, tolerable and safe as 600mg of intravaginal capsules for luteal support in IVF pregnancies. This study will be conducted at several study sites and neither the patient or the doctor will know which of the two different treatments a patient will receive.Female infertilityMedDRA version: 19.0Level: LLTClassification code 10003540Term: Assisted fertilizationSystem Organ Class: 100000004865
EUCTR2012-002215-26-ATAbbott Laboratories GmbH1,066
进行中(未招募)
1 期
A study to compare if 30mg of oral Dydrogesterone is as good, tolerable and safe as 600mg of intravaginal capsules for luteal support in IVF pregnancies. This study will be conducted at several study sites and neither the patient or the doctor will know which of the two different treatments a patient will receive.Female infertilityMedDRA version: 14.1Level: LLTClassification code 10003540Term: Assisted fertilizationSystem Organ Class: 100000004865
EUCTR2012-002215-26-FIAbbott Laboratories GmbH1,066